Literature DB >> 9749762

Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat.

R Steinberg1, N Marco, B Voutsinos, M Bensaid, D Rodier, J Souilhac, R Alonso, F Oury-Donat, G Le Fur, P Soubrie.   

Abstract

We examined the expression and presence of NK2 receptors in the septal area of rat brain, and investigated their functional role in the regulation of the septohippocampal cholinergic system. Using reverse transcription-polymerase chain reaction (RT-PCR) analysis, we showed the presence of NK2 receptor mRNA expression in the septal area, and detected septal NK2 binding sites by using a fluorescent-tagged neurokinin A (NKA) derivative. In vivo microdialysis was employed to explore the functional role of NK2 receptors in the release of hippocampal acetylcholine evoked by tactile stimulation in freely moving rats. Two sessions of stroking of the neck and back of the rat for 30 min, at 90 min intervals, produced a marked and reproducible increase in hippocampal acetylcholine release. This effect was dose-dependently prevented by intraperitoneal administration of the two selective non-peptide tachykinin NK2 receptor antagonists SR144190 (0.03-0.3 mg/kg, i.p.) and SR48968 (0.3 and 1 mg/kg, i.p.), but not by the inactive enantiomer of SR48968 (SR48965, 1 mg/kg) nor by the two non-peptide NK1 receptor antagonists SR140333 (3 mg/kg, i.p.) and GR205171 (1 mg/kg, i.p.). Furthermore, the intraseptal application of SR144190 (10(-8) M) reduced the sensory response. Finally, intraseptal perfusion of neurokinin A (0.01-10 microM) in anaesthetized rats produced a concentration-dependent increase in hippocampal acetylcholine release. The response to neurokinin A (0.1 microM) was prevented by SR144190 (0.03-0.3 mg/kg, i.p.) and SR48968 (0.3-1 mg/kg, i.p.). In conclusion, this study provides direct evidence for the role of endogenous NKA/substance P, through the activation of NK2 receptors, in regulating the septohippocampal cholinergic function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749762     DOI: 10.1046/j.1460-9568.1998.00244.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

1.  Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.

Authors:  S B Mazzone; D P Geraghty
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.

Authors:  Maria A de Souza Silva; Bernd Lenz; Andrea Rotter; Teresa Biermann; Oliver Peters; Alfredo Ramirez; Frank Jessen; Wolfgang Maier; Michael Hüll; Johannes Schröder; Lutz Frölich; Stefan Teipel; Oliver Gruber; Johannes Kornhuber; Joseph P Huston; Christian P Müller; Sandra Schäble
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-27       Impact factor: 11.205

Review 3.  Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression.

Authors:  Konstantinos A Paschos; Stavroula Veletza; Ekaterini Chatzaki
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

4.  Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.

Authors:  Marie-Louise Kemel; Sylvie Pérez; Gérard Godeheu; Philippe Soubrié; Jacques Glowinski
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

5.  Neurokinin receptor mechanisms in forebrain medial septum modulate nociception in the formalin model of inflammatory pain.

Authors:  Si Yun Ng; Mohammed Zacky Ariffin; Sanjay Khanna
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.